Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions. According to a research company, a market intelligence company specializing in global connectivity and emerging technology, drug counterfeiting is a worldwide criminal enterprise, costing drug manufacturers $30 billion a year in lost revenue and brand deterioration.
SMi's masterclass will provide an intensive look at methods to combat counterfeiting and diversion, focusing on three key pillars: physical, digital and process security.
Why should you attend
Understand the current criminal threats to your supply chain
Analyse and debate the best strategies to keep products secure and patients safe
Get the latest information on how forthcoming legal requirements in EU, US and elsewhere will affect your organisation
Learn how to turn must-do compliance into added-value opportunity
Network with and learn from other senior industry representative
This Masterclass Host
Mark Davison, CEO, Blue Sphere Health
Mark Davison is a leading global expert on counterfeiting and diversion and the author of "Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs" (Wiley, N.Y., 2011). As well as running Blue Sphere Health, he is active on several external committees and industry standards leadership teams. Over a 25 year career he has held senior roles in big pharma, biotech, Contract Research Organisations and security system vendors.
For full conference programme please visit: www.smi-online.co.uk/2014anti-counterfeiting7.asp
Alternatively please contact: Daniel Lee on +44 (0) 207 827 6078 or email at firstname.lastname@example.org
Standard Rate: £599
Speakers: Mark Davison, CEO, Blue Sphere Health